-
EU fines Google 890 mn euros, risking US fury
-
Norway set to make formal complaint to FIFA over Balogun red card saga
-
France evacuates thousands of tourists as fire rages in pine forest
-
Floods in northeast India kill at least 41
-
French Jewish DJ sues after activists disrupt stage show: lawyer
-
Nestle siphons off bottled water business into joint venture
-
Nokia says AI, cloud boosted sales in second quarter
-
Hundreds hospitalised in Japan heatwave 'disaster'
-
Repsol says profit more than triples on higher oil prices
-
Renault says sales stalled in first half
-
TotalEnergies says profit doubled on Mideast war
-
EasyJet says profits nosedive on Mideast war
-
Giant swing on Swiss peak aims to boost summer tourism as Alps warm
-
Modi vows punishment for exam fraud fuelling India protests
-
ASEAN to call for open straits as US-Iran war casts shadow
-
Six candidates in race to lead UN set for televised debate
-
AI catches up with humans to score 100% at top maths contest
-
Comic-Con kicks off with Marvel's return
-
South Korea election office raided in fake turnout figures probe: investigators
-
Dutch riders dreaming of crazy party corner of Alpe d'Huez
-
Killer whales: orcas blow fish to bits 'for fun', study finds
-
Houthis target Red Sea shipping as US hits Iran
-
Deadly wildfires force thousands from homes in parts of Europe
-
Record-equalling Red Sox streak halted at 15 wins
-
Tech bounce lifts Asia stocks, oil extends gains on US-Iran fears
-
Messi-less Miami beat Fire 3-2 to spoil Lewandowski's MLS debut
-
Surrounded by militias, Sudanese fear endless cycle of war
-
Mercedes expect Hungary challenge from Hamilton and Ferrari
-
Commonwealth Games 'where champions are made' despite slimmed down model, argues president
-
In Ghana, one man's race to save critically endangered fish
-
Trump family project in Albania has already caused 'irreparable' damage: NGOs
-
Wilson captain, Slipper absent in Kiss's first Wallabies squad
-
Bollywood blast master keeps it real with fire and fury
-
New Mideast fighting puts eurozone rate-setters on alert
-
Tearful fights, edible offerings: A glimpse into the Maradona trial
-
Venezuelans search for animal companions lost in the quakes
-
What's the deal with peptides? The hyped market under US review
-
Argentine Football Association says US did not detain its president
-
Tesla shares fall as Musk touts ambitious -- and costly -- plans
-
June heatwave cost UK economy more than £1bn: study
-
Houthis claim Red Sea tanker strikes as US hits Iran again
-
Google-parent Alphabet beats expectations, cloud revenue nearly doubles
-
Wildfires ravage parts of southern France, Italy and Spain
-
US announces civilian nuclear deal with Saudi Arabia
-
Alphabet beats expectations in second quarter, cloud revenue nearly doubles
-
Tesla shares dip after profit misses expectations
-
Trump threatens Iran infrastructure, Tehran vows 'eye for eye'
-
Red Sox tie club record with 15th straight MLB win
-
US teen withdraws lawsuit against Meta over social media addiction
-
US eyes offshore nuclear reactors
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
O.Schlaepfer--VB